996.0000 10.05 (1.02%)
NSE Oct 09, 2025 12:50 PM
Volume: 1.1M
 

996.00
1.02%
Karvy
We upgrade our Revenues by 1.8%/2.8% in FY20E/FY21E due to upgrade in USand EM business. We downgrade our EBITDAM by 40bps to 18.9% for FY20Ewhile we maintain our EBITDAM for FY21E.
Zydus Lifesciences Ltd. is trading below its 30 day SMA of 1012.2
More from Zydus Lifesciences Ltd.
Recommended